← Back to headlines
Merck Reaches Nearly $6 Billion Deal for Cancer Biotech Terns
Merck has finalized a deal worth nearly $6 billion to acquire Terns, a cancer biotech company, signaling a major acquisition in the pharmaceutical and biotechnology sector.
25 Mar, 13:14 — 25 Mar, 13:14
Sources
Showing 1 of 1 sources
Related Stories
Philippine Charity Sweepstakes Office Provides ₱18.2M Aid to Mindoro Healthcare
just now
NGO Provides Health Insurance for Pregnant Women in Enugu
just now
Philippines clears irrigation canals in Bicol to mitigate El Niño impact
just now
Kwara State Government Pledges Improved Immunisation Efforts
just now